drugset / Trial / NCT06383897
Phase 1 Study in Healthy Participants and Participants With Kidney Dysfunction
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized, double-blind, placebo-controlled, dose-escalation clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics, and the impact of food on pharmacokinetics of oral HS-10398 in Chinese healthy participants, and a clinical trial to assess the pharmacokinetic characteristics of oral HS-10398 in Chinese participants with kidney dysfunction
Timeline
- Start
- 2024-05-31
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10398 | Unknown | — | Oral |
Indications
No indication recorded.